| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00795-013-0028-X |
| P698 | PubMed publication ID | 23471757 |
| P50 | author | Sun-Young Jun | Q79979361 |
| Ghee Young Kwon | Q86913049 | ||
| P2093 | author name string | Chan Choi | |
| Hyun-Jung Kim | |||
| Weon Seo Park | |||
| Yong Wook Park | |||
| Soomin Ahn | |||
| Yong Mee Cho | |||
| Jung Won Shim | |||
| P2860 | cites work | Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis | Q33282233 |
| Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis | Q33502342 | ||
| Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas | Q33587610 | ||
| Molecular diagnosis and therapy of kidney cancer | Q34065685 | ||
| Genomic profiling of renal cell carcinoma in patients with end-stage renal disease | Q34092758 | ||
| Abundant intracytoplasmic hemosiderin in both histiocytes and neoplastic cells: A diagnostic pitfall in fine-needle aspiration of cystic papillary renal-cell carcinoma | Q34136269 | ||
| Sunitinib in patients with metastatic renal cell carcinoma | Q34568166 | ||
| Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney | Q35058062 | ||
| Hemosiderin laden macrophages and hemosiderin within follicular cells distinguish benign follicular lesions from follicular neoplasms. | Q37183639 | ||
| Targeting the Met signaling pathway in renal cancer. | Q37331862 | ||
| EAU guidelines on renal cell carcinoma: the 2010 update | Q37773064 | ||
| What can molecular pathology contribute to the management of renal cell carcinoma? | Q37864528 | ||
| Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects | Q37900536 | ||
| Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer | Q37910970 | ||
| Targeting MET in cancer: rationale and progress | Q37978193 | ||
| MET expression in sporadic renal cell carcinomas | Q42058275 | ||
| Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. | Q42754881 | ||
| Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, an | Q43066528 | ||
| Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy | Q43129397 | ||
| Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. | Q46006772 | ||
| Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy | Q46081666 | ||
| Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study | Q46379037 | ||
| Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma | Q47650026 | ||
| Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features | Q50556506 | ||
| NCCN clinical practice guidelines in oncology: kidney cancer | Q59571714 | ||
| Renal siderosis in patients with heart-valve prostheses: clinical implications | Q68381956 | ||
| Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study | Q71872972 | ||
| Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia | Q82363108 | ||
| Imprint cytological findings of acquired cystic disease-associated renal-cell carcinoma: a close relationship to papillary renal-cell carcinoma | Q84383370 | ||
| Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma | Q84438149 | ||
| Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma | Q84596280 | ||
| P433 | issue | 4 | |
| P921 | main subject | Acquired cystic kidney disease-associated renal cell carcinoma | Q16819853 |
| P304 | page(s) | 225-232 | |
| P577 | publication date | 2013-03-08 | |
| P1433 | published in | Medical Molecular Morphology | Q26842452 |
| P1476 | title | Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features | |
| P478 | volume | 46 |
| Q54235329 | Cancer in patients with inherited ciliopathies: polycystic kidney disease. |
| Q33787087 | Development of pathological diagnostics of human kidney cancer by multiple staining using new fluorescent Fluolid dyes |
| Q88028266 | Foamy cell (hibernoma-like) change is a rare histopathological feature in renal cell carcinoma |
| Q26752945 | Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas |
Search more.